Name: BioStock Intestor Meeting: Interview with Redwood Pharma
Uploaded: 2022-09-27T08:15:07+02:00
Channel: Kim Liedholm
Description: At BioStock Investor Meeting Redwood Pharma CEO Martin Vidaeus told us more about RP501 and RP101, aimed at the treatment of dry eyes.

BioStock Intestor Meeting: Interview with Redwood Pharma

27 September, 2022

RedwoodPharma_MartinVidaeus_BioStockInvestorMeeting

BioStock Investor Meeting: Redwood Pharma presents

21 September, 2022

Tag: RP101

BioStock Intestor Meeting: Interview with Redwood Pharma

BioStock Investor Meeting: Redwood Pharma presents